Biomarker Technologies(BMKGENE) is an industry-leading genomics service provider, headquartered in Beijing. It has been actively engaged in innovation and developing high-throughput sequencing technologies and bioinformatics for over 13 years. With a passionate and highly-skilled R&D team , BMKGENE is committed to providing the most comprehensive sequencing services covering genomics, transcriptomics, single-cell omics and epigenetics.
Biomarker Technologies provides ONE-STOP solutions on multi-omics levels that fulfill diverse research goals
Biomarker Technologies owns the most cutting-edge high-throughput sequencing platforms and high-performance computing platforms, serving for next-generation sequencing, third-generation sequencing, single-cell multiomics, proteomics, metabolomics and high-throughput data handling.
Our outstanding technical team has robust ability in tackling scientific and technical issues and has accumulated massive experience in diverse research area and contributed in hundreds of high-impact publications in Nature, Nature Genetics, Nature Communications, Plant Cell, etc. It owns over 60 nation patents of inventions and 200 software copyrights.
Biomarker Technologies is committed to continuously creat greater value for its customers and lead the industrial transformation with high-quality innovations to realize its ultimate mission of benefiting humanity with genetic technology.
For inquiries about our products or pricelist, please leave your email to us and we will be in touch within 24 hours.Inquiry now